Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial

Autor: Fransson, Per *, Nilsson, Per, Gunnlaugsson, Adalsteinn, Beckman, Lars, Tavelin, Björn, Norman, David, Thellenberg-Karlsson, Camilla, Hoyer, Morten, Lagerlund, Magnus, Kindblom, Jon, Ginman, Claes, Johansson, Bengt, Björnlinger, Kirsten, Seke, Mihajl, Agrup, Måns, Zackrisson, Björn, Kjellén, Elisabeth, Franzén, Lars, Widmark, Anders
Zdroj: In The Lancet Oncology February 2021 22(2):235-245
Databáze: ScienceDirect